Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Carcinoma, Pancreatic Ductal

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kohi, S1
Sato, N1
Koga, A1
Matayoshi, N1
Hirata, K1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Carcinoma, Pancreatic Ductal

ArticleYear
KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
    Oncotarget, 2017, Mar-07, Volume: 8, Issue:10

    Topics: Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation

2017